Swiss National Bank
PRTK

Swiss National Bank’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Swiss National Bank’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-49,800
Closed -$267K – 2576
2019
Q1 		$267K Buy
49,800
+3,100
+7% +$20K ﹤0.01% 2474
2018
Q4 		$240K Hold
46,700
– – ﹤0.01% 2505
2018
Q3 		$453K Hold
46,700
– – ﹤0.01% 2432
2018
Q2 		$476K Hold
46,700
– – ﹤0.01% 2458
2018
Q1 		$607K Buy
46,700
+12,200
+35% +$182K ﹤0.01% 2312
2017
Q4 		$618K Hold
34,500
– – ﹤0.01% 2346
2017
Q3 		$866K Buy
34,500
+4,400
+15% +$102K ﹤0.01% 2143
2017
Q2 		$725K Buy
30,100
+4,100
+16% +$90.6K ﹤0.01% 2247
2017
Q1 		$501K Hold
26,000
– – ﹤0.01% 2375
2016
Q4 		$400K Buy
26,000
+5,100
+24% +$66.2K ﹤0.01% 2465
2016
Q3 		$272K Hold
20,900
– – ﹤0.01% 2497
2016
Q2 		$291K Buy
20,900
+5,500
+36% +$81K ﹤0.01% 2520
2016
Q1 		$224K Buy
15,400
+3,400
+28% +$52K ﹤0.01% 2545
2015
Q4 		$228K Buy
+12,000
New +$229K ﹤0.01% 2553

Other funds holding PRTK

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Swiss National Bank's PRTK Position: Q2 2019 in Review

Swiss National Bank sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2019, closing a stake of 49,800 shares — an estimated $267K sold.

Swiss National Bank first reported a position in PRTK in Q4 2015 and held it in 14 quarters. The position peaked at $866K in Q3 2017. 89 funds tracked by Wall St. Rank hold PRTK as of Q2 2019.

  • Swiss National Bank reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Swiss National Bank sold 49,800 Paratek Pharmaceuticals, Inc. shares in Q2 2019, an estimated $267K.
  • Swiss National Bank first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
  • Swiss National Bank's Paratek Pharmaceuticals, Inc. position peaked at $866K in Q3 2017.
  • 89 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2019.

Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.